Pursuant to Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, as amended from time to time, Senores Pharmaceuticals has informed that the officials of the Company will be meeting Analysts/ Investors at its Corporate Office situated in Ahmedabad, Gujarat as per the details enclosed. Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
The above information is a part of company’s filings submitted to BSE.
